Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Parasite deoxyribonucleic acid (DNA) is the fundamental genetic material of parasitic organisms, including protozoa and helminths, and serves as a primary target for several classes of antiparasitic drugs. It encompasses nuclear DNA as well as specialized organellar DNA, such as the kinetoplast DNA (kDNA) in trypanosomatids and the apicoplast DNA in apicomplexans. Therapeutic agents target parasite DNA through various mechanisms, including minor groove binding, intercalation, and the generation of reactive radicals that induce lethal strand breaks. For instance, diamidines like pentamidine bind to AT-rich regions of the minor groove, while nitroimidazoles like metronidazole are reduced to toxic intermediates that damage the DNA structure. These interactions disrupt essential processes such as DNA replication and transcription, ultimately leading to the cessation of parasite growth and cell death. The selectivity of these drugs often relies on the unique composition of parasite genomes or the presence of specific metabolic pathways for drug activation that are absent in the host. Despite their efficacy, the use of DNA-targeting drugs is often limited by concerns regarding host genotoxicity and the rapid development of resistance through genetic mutations.
DNA intercalation, minor groove binding, induction of DNA strand breaks via reactive radicals, and inhibition of DNA replication and transcription.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Parasite deoxyribonucleic acid (DNA) (DNA).